To determine whether dysregulation of PI3K signaling is associated with increased WNT expression, we utilized a previously described GEMM of pancreatic cancer harboring an oncogenic Kras mutation and deletion of Pten (KCPTEN) (Kennedy et al., 2011; Morran et al., 2014). This evidence concerns the gene PTEN and pancreatic neoplasm.